US dairy company Borden has released new Borden Kid Builder, the firm’s first 2% no-sugar-added milk for kids, as per the latest dairy industry news. The dairy product with 50% more protein (13g per 240mL serving) and calcium (490mg per 240mL serving) than regular milk made from non-rbST treated cows. Nick Suffredin – vice president […]
US-based veterinary pharmaceuticals producer Elanco Animal Health has agreed to acquire German drug giant Bayer’s animal health business for $7.6 billion, financed by a combination of 70% cash and 30% equity. The transaction, which enhances emerging market presence and strengthens cattle business, will strengthen Elanco’s Innovation, Portfolio, and Productivity (IPP) strategy, creating the second largest […]
The post Bayer to divest animal health business to Elanco for $7.6bn appeared first on PharmaNewsDaily.com.
Senior Congress leader and former Finance Minister P Chidambaram was missing for the past 27 hours after the Delhi High Court refused to grant him […]
Indian student Sumedh Mannar drowned in the Crater Lake in the US state of Oregon after he dove off the Jumping Rock, a recreation spot […]
Three people were killed when a helicopter hit the cable and crashed in Uttarkashi of Uttarakhand. It was carrying relief material for the victims in […]
An armed bus hijacker has been shot dead by the police, who took passengers of a bus hostage on the Rio-Nitero bridge in Brazil. The […]
Actor Raj Tarun had a narrow escape after his car hit a compound wall on the ORR near Alkapur under Narsingi police station limits of […]
US biopharma company Eiger BioPharmaceuticals said that peginterferon lambda (Lambda) has been granted breakthrough therapy designation from the US Food and Drug Administration (FDA) for the treatment of hepatitis delta virus (HDV) infection. Breakthrough therapy designation enables expedition of the development and review of drugs intended for the treatment of a serious condition and where […]
The post Eiger bags FDA breakthrough therapy status for HDV drug candidate Lambda appeared first on PharmaNewsDaily.com.
SNK01-MX03 clinical trial : NKMax America, a US biotech company, has initiated a phase 1 trial called SNK01-MX03 to investigate its ex vivo expanded autologous natural killer cell therapeutic SNK in plaque psoriasis. In this connection, NKMax America treated the first patient in the SNK01-MX03 clinical trial, which is a single center, dose-escalation study for […]
The post NKMax America launches SNK01-MX03 clinical trial in plaque psoriasis appeared first on PharmaNewsDaily.com.